Neurotransmitters as Regulators of Tumor Angiogenesis and Immunity: The Role of Catecholamines
The growing tumor employs various strategies to establish its growth, progression and spread in the host. Angiogenesis or formation of new blood vessels from existing ones and escape from immune surveillance are the two critical steps that ensure proper establishment and growth of the newly formed t...
Gespeichert in:
| Veröffentlicht in: | Journal of neuroimmune pharmacology 2013-03, Vol.8 (1), p.7-14 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 14 |
|---|---|
| container_issue | 1 |
| container_start_page | 7 |
| container_title | Journal of neuroimmune pharmacology |
| container_volume | 8 |
| creator | Sarkar, Chandrani Chakroborty, Debanjan Basu, Sujit |
| description | The growing tumor employs various strategies to establish its growth, progression and spread in the host. Angiogenesis or formation of new blood vessels from existing ones and escape from immune surveillance are the two critical steps that ensure proper establishment and growth of the newly formed tumor. Thus understanding the novel pathways associated with tumor angiogenesis and immunity may lead to the development of newer therapeutic strategies using the regulators of these pathways to improve patient outcomes. These two pivotal steps in the process of tumorigenesis are governed by plethora of endogenous factors. The neuroendocrine molecules, which include the catecholamine neurotransmitters, dopamine, norepinephrine and epinephrine are of growing interest considering their varied and diverse regulatory roles both in the process of tumor angiogenesis and tumor immunity. This review focuses on the emerging roles of catecholamines in modulating tumor angiogenesis and immunity, and also discusses the probable molecular mechanisms of their actions. Understanding of this new group of endogenous regulators of tumor growth may lead to the development of newer therapeutic approaches for the treatment of cancer. |
| doi_str_mv | 10.1007/s11481-012-9395-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3869381</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1314332922</sourcerecordid><originalsourceid>FETCH-LOGICAL-c569t-9203ad1332be4fda7aead4da012e8b09b27f5212aada7f9ac0aa29174eba4e353</originalsourceid><addsrcrecordid>eNqFkU1r3DAQhk1paNKkP6CXYuilF7cafaysHgph6UcgJBC214qxPfYq2FIq2YH8-2q7SUgLpSdJzDPv6J23KF4Dew-M6Q8JQNZQMeCVEUZV-llxBErpCgyTzx_utWGHxcuUrhmTUjL2ojjkvK5X9cocFT8uaIlhjujT5OaZYioxlVc0LCPOIb9CX26WKcTy1A8uDOQpucz4rjybpsW7-e5judlSeRVG2sFrnKndhhEnl9GT4qDHMdGr-_O4-P7l82b9rTq__Hq2Pj2vWrUyc2U4E9iBELwh2XeokbCTHWZnVDfMNFz3igNHzLXeYMsQuQEtqUFJQonj4tNe92ZpJupa8tnSaG-imzDe2YDO_lnxbmuHcGtF3oKoIQu8uxeI4edCabaTSy2NI3oKS7IguWZMCab-jwqQ2YnhPKNv_0KvwxJ93oQFo5iuYfVbEPZUG0NKkfrHfwOzu6DtPmib12F3QVude948NfzY8ZBsBvgeSLnkB4pPRv9T9RfCcLUX</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1950781605</pqid></control><display><type>article</type><title>Neurotransmitters as Regulators of Tumor Angiogenesis and Immunity: The Role of Catecholamines</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Sarkar, Chandrani ; Chakroborty, Debanjan ; Basu, Sujit</creator><creatorcontrib>Sarkar, Chandrani ; Chakroborty, Debanjan ; Basu, Sujit</creatorcontrib><description>The growing tumor employs various strategies to establish its growth, progression and spread in the host. Angiogenesis or formation of new blood vessels from existing ones and escape from immune surveillance are the two critical steps that ensure proper establishment and growth of the newly formed tumor. Thus understanding the novel pathways associated with tumor angiogenesis and immunity may lead to the development of newer therapeutic strategies using the regulators of these pathways to improve patient outcomes. These two pivotal steps in the process of tumorigenesis are governed by plethora of endogenous factors. The neuroendocrine molecules, which include the catecholamine neurotransmitters, dopamine, norepinephrine and epinephrine are of growing interest considering their varied and diverse regulatory roles both in the process of tumor angiogenesis and tumor immunity. This review focuses on the emerging roles of catecholamines in modulating tumor angiogenesis and immunity, and also discusses the probable molecular mechanisms of their actions. Understanding of this new group of endogenous regulators of tumor growth may lead to the development of newer therapeutic approaches for the treatment of cancer.</description><identifier>ISSN: 1557-1890</identifier><identifier>EISSN: 1557-1904</identifier><identifier>DOI: 10.1007/s11481-012-9395-7</identifier><identifier>PMID: 22886869</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Angiogenesis ; Angiogenesis Inhibitors - therapeutic use ; Animals ; Biomedical and Life Sciences ; Biomedicine ; Catecholamines - physiology ; Cell Biology ; Dopamine - physiology ; Epinephrine - physiology ; Humans ; Immunology ; Neoplasms - immunology ; Neoplasms - pathology ; Neovascularization, Pathologic - immunology ; Neovascularization, Pathologic - pathology ; Neurosciences ; Neurotransmitter Agents - physiology ; Norepinephrine - physiology ; Perspective ; Pharmacology/Toxicology ; Virology</subject><ispartof>Journal of neuroimmune pharmacology, 2013-03, Vol.8 (1), p.7-14</ispartof><rights>Springer Science+Business Media, LLC 2012</rights><rights>Journal of Neuroimmune Pharmacology is a copyright of Springer, 2013.</rights><rights>Springer Science+Business Media, LLC 2012 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c569t-9203ad1332be4fda7aead4da012e8b09b27f5212aada7f9ac0aa29174eba4e353</citedby><cites>FETCH-LOGICAL-c569t-9203ad1332be4fda7aead4da012e8b09b27f5212aada7f9ac0aa29174eba4e353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11481-012-9395-7$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11481-012-9395-7$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,315,781,785,886,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22886869$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sarkar, Chandrani</creatorcontrib><creatorcontrib>Chakroborty, Debanjan</creatorcontrib><creatorcontrib>Basu, Sujit</creatorcontrib><title>Neurotransmitters as Regulators of Tumor Angiogenesis and Immunity: The Role of Catecholamines</title><title>Journal of neuroimmune pharmacology</title><addtitle>J Neuroimmune Pharmacol</addtitle><addtitle>J Neuroimmune Pharmacol</addtitle><description>The growing tumor employs various strategies to establish its growth, progression and spread in the host. Angiogenesis or formation of new blood vessels from existing ones and escape from immune surveillance are the two critical steps that ensure proper establishment and growth of the newly formed tumor. Thus understanding the novel pathways associated with tumor angiogenesis and immunity may lead to the development of newer therapeutic strategies using the regulators of these pathways to improve patient outcomes. These two pivotal steps in the process of tumorigenesis are governed by plethora of endogenous factors. The neuroendocrine molecules, which include the catecholamine neurotransmitters, dopamine, norepinephrine and epinephrine are of growing interest considering their varied and diverse regulatory roles both in the process of tumor angiogenesis and tumor immunity. This review focuses on the emerging roles of catecholamines in modulating tumor angiogenesis and immunity, and also discusses the probable molecular mechanisms of their actions. Understanding of this new group of endogenous regulators of tumor growth may lead to the development of newer therapeutic approaches for the treatment of cancer.</description><subject>Angiogenesis</subject><subject>Angiogenesis Inhibitors - therapeutic use</subject><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Catecholamines - physiology</subject><subject>Cell Biology</subject><subject>Dopamine - physiology</subject><subject>Epinephrine - physiology</subject><subject>Humans</subject><subject>Immunology</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - pathology</subject><subject>Neovascularization, Pathologic - immunology</subject><subject>Neovascularization, Pathologic - pathology</subject><subject>Neurosciences</subject><subject>Neurotransmitter Agents - physiology</subject><subject>Norepinephrine - physiology</subject><subject>Perspective</subject><subject>Pharmacology/Toxicology</subject><subject>Virology</subject><issn>1557-1890</issn><issn>1557-1904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkU1r3DAQhk1paNKkP6CXYuilF7cafaysHgph6UcgJBC214qxPfYq2FIq2YH8-2q7SUgLpSdJzDPv6J23KF4Dew-M6Q8JQNZQMeCVEUZV-llxBErpCgyTzx_utWGHxcuUrhmTUjL2ojjkvK5X9cocFT8uaIlhjujT5OaZYioxlVc0LCPOIb9CX26WKcTy1A8uDOQpucz4rjybpsW7-e5judlSeRVG2sFrnKndhhEnl9GT4qDHMdGr-_O4-P7l82b9rTq__Hq2Pj2vWrUyc2U4E9iBELwh2XeokbCTHWZnVDfMNFz3igNHzLXeYMsQuQEtqUFJQonj4tNe92ZpJupa8tnSaG-imzDe2YDO_lnxbmuHcGtF3oKoIQu8uxeI4edCabaTSy2NI3oKS7IguWZMCab-jwqQ2YnhPKNv_0KvwxJ93oQFo5iuYfVbEPZUG0NKkfrHfwOzu6DtPmib12F3QVude948NfzY8ZBsBvgeSLnkB4pPRv9T9RfCcLUX</recordid><startdate>20130301</startdate><enddate>20130301</enddate><creator>Sarkar, Chandrani</creator><creator>Chakroborty, Debanjan</creator><creator>Basu, Sujit</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20130301</creationdate><title>Neurotransmitters as Regulators of Tumor Angiogenesis and Immunity: The Role of Catecholamines</title><author>Sarkar, Chandrani ; Chakroborty, Debanjan ; Basu, Sujit</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c569t-9203ad1332be4fda7aead4da012e8b09b27f5212aada7f9ac0aa29174eba4e353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Angiogenesis</topic><topic>Angiogenesis Inhibitors - therapeutic use</topic><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Catecholamines - physiology</topic><topic>Cell Biology</topic><topic>Dopamine - physiology</topic><topic>Epinephrine - physiology</topic><topic>Humans</topic><topic>Immunology</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - pathology</topic><topic>Neovascularization, Pathologic - immunology</topic><topic>Neovascularization, Pathologic - pathology</topic><topic>Neurosciences</topic><topic>Neurotransmitter Agents - physiology</topic><topic>Norepinephrine - physiology</topic><topic>Perspective</topic><topic>Pharmacology/Toxicology</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sarkar, Chandrani</creatorcontrib><creatorcontrib>Chakroborty, Debanjan</creatorcontrib><creatorcontrib>Basu, Sujit</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neuroimmune pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sarkar, Chandrani</au><au>Chakroborty, Debanjan</au><au>Basu, Sujit</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurotransmitters as Regulators of Tumor Angiogenesis and Immunity: The Role of Catecholamines</atitle><jtitle>Journal of neuroimmune pharmacology</jtitle><stitle>J Neuroimmune Pharmacol</stitle><addtitle>J Neuroimmune Pharmacol</addtitle><date>2013-03-01</date><risdate>2013</risdate><volume>8</volume><issue>1</issue><spage>7</spage><epage>14</epage><pages>7-14</pages><issn>1557-1890</issn><eissn>1557-1904</eissn><abstract>The growing tumor employs various strategies to establish its growth, progression and spread in the host. Angiogenesis or formation of new blood vessels from existing ones and escape from immune surveillance are the two critical steps that ensure proper establishment and growth of the newly formed tumor. Thus understanding the novel pathways associated with tumor angiogenesis and immunity may lead to the development of newer therapeutic strategies using the regulators of these pathways to improve patient outcomes. These two pivotal steps in the process of tumorigenesis are governed by plethora of endogenous factors. The neuroendocrine molecules, which include the catecholamine neurotransmitters, dopamine, norepinephrine and epinephrine are of growing interest considering their varied and diverse regulatory roles both in the process of tumor angiogenesis and tumor immunity. This review focuses on the emerging roles of catecholamines in modulating tumor angiogenesis and immunity, and also discusses the probable molecular mechanisms of their actions. Understanding of this new group of endogenous regulators of tumor growth may lead to the development of newer therapeutic approaches for the treatment of cancer.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>22886869</pmid><doi>10.1007/s11481-012-9395-7</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1557-1890 |
| ispartof | Journal of neuroimmune pharmacology, 2013-03, Vol.8 (1), p.7-14 |
| issn | 1557-1890 1557-1904 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3869381 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Angiogenesis Angiogenesis Inhibitors - therapeutic use Animals Biomedical and Life Sciences Biomedicine Catecholamines - physiology Cell Biology Dopamine - physiology Epinephrine - physiology Humans Immunology Neoplasms - immunology Neoplasms - pathology Neovascularization, Pathologic - immunology Neovascularization, Pathologic - pathology Neurosciences Neurotransmitter Agents - physiology Norepinephrine - physiology Perspective Pharmacology/Toxicology Virology |
| title | Neurotransmitters as Regulators of Tumor Angiogenesis and Immunity: The Role of Catecholamines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T01%3A31%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurotransmitters%20as%20Regulators%20of%20Tumor%20Angiogenesis%20and%20Immunity:%20The%20Role%20of%20Catecholamines&rft.jtitle=Journal%20of%20neuroimmune%20pharmacology&rft.au=Sarkar,%20Chandrani&rft.date=2013-03-01&rft.volume=8&rft.issue=1&rft.spage=7&rft.epage=14&rft.pages=7-14&rft.issn=1557-1890&rft.eissn=1557-1904&rft_id=info:doi/10.1007/s11481-012-9395-7&rft_dat=%3Cproquest_pubme%3E1314332922%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1950781605&rft_id=info:pmid/22886869&rfr_iscdi=true |